Can Democrats win Maha voters after Trump let them down? The party is hoping they can integrate the public health message with grassroots concern, but leave behind conspiracy theories The Guardian - US · Oct 31
Your Medication Looks Different This Month — 5 Things to Check Before Taking It You’ve been taking the same prescription for years, so you know exactly what the pills look like. But when you open your latest refill, something... Saving Advice · Oct 30
Infant Formula Would Need More Vitamin D and Iodine Under FDA Proposal, While Current Formulas Remain Safe The FDA has proposed new vitamin D, iodine, manganese and vitamin A standards for infant formula, while emphasizing that current products remain safe and families need not change brands. Medical Daily · Oct 30
Medline Beds Linked to 2 Deaths and 16 Serious Injuries Draw FDA Fire and Entrapment Alert for Caregivers The FDA warns that Medline-brand homecare, bariatric and long-term care beds may overheat or cause entrapment, citing two deaths and 16 serious injuries reported by Medline. Medical Daily · Oct 30
Hibsago Approval Gives Some Hepatitis B Patients a Shot at Functional Cure, Reached by About 1 in 5 The FDA approved Hibsago for certain adults with chronic hepatitis B after trials found 19% maintained viral control after stopping treatment, though serious risks remain. Medical Daily · Oct 30
New Salmonella Javiana Outbreak Sickens 59 as FDA Investigators Search for a Food Source Not Yet Identified The FDA is investigating 59 illnesses linked to Salmonella Javiana but has not identified a food source. Health officials urge symptom awareness and standard food safety precautions. Medical Daily · Oct 30
Rep. Steve Cohen Thinks the DEA Shouldn't Be Practicing Medicine Cohen on Thursday introduced a proposed overhaul of the Controlled Substances Act, challenging decades of misguided assumptions. Reason · Oct 29
Six Wellness Peptides Get Wider Prescription Access Under New HHS Policy. An Industry Player Praised is as a 'Great Step.' The Department of Health and Human Services announced that compounding pharmacies could prepare specific peptides for individual patients under specified conditions. International Business Times · Oct 29
RFK Jr. Institutes Backdoor Approval of 6 Peptides The policy balances patient safety with “patient choice and freedom," HHS says. Reason · Oct 29
HHS Lets Pharmacies Compound BPC-157 and Five Other Unapproved Peptides Despite FDA Scientists' Safety Concerns HHS will not pursue enforcement against qualifying pharmacies that compound six unapproved peptides, but the agency says the policy does not establish their safety or effectiveness. Medical Daily · Oct 29
Backed by Joe Rogan, health boss RFK Jr scraps restrictions on unapproved injections IN FULL The Independent UK · Oct 29
FDA scientists opposed the Trump administration's effort to ease peptides access Food and Drug Administration scientists did not support an effort by President Donald Trump's administration to loosen rules on unproven peptide drugs The Independent UK · Oct 28
Server says customer ordered clams despite having a severe allergy: ‘If you die… [that’s] kinda on you Disclosing your food allergy is a serious matter. We Got This Covered · Oct 28
Dementia cases in US projected to rise dramatically by 2050, study finds Increase will add strain on a healthcare system already struggling amid cuts by Trump administration The Guardian - US · Oct 28
The Guardian - US · Oct 27 Doctor removes prostate from 35 miles away in first telerobotic surgery in US The patient was at a facility in Minneola, Florida, while the surgeon operated remotely from another facility
The Independent UK · Oct 27 Shockingly few imported fruits and vegetables under US inspection despite the summer’s ‘explosive diarrhea’ outbreak The FDA inspected only 7.6 percent of foreign produce facilities over the last decade, leaving millions of tons of imported fruits and vegetables unchecked each year
The Economic Times · Oct 27 Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2% Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-year decline in revenue from operations, totaling Rs 7,404 crore. Additionally, a significant 26.7% decrease in EBITDA resulted in a lower margin of 18.7%. Nonetheless, Cipla's One…
Roll Call · Oct 26 Backer of hemp regulation looks to reconciliation process - Roll Call Backer of hemp regulation looks to reconciliation process - Uncategorized
Saving Advice · Oct 26 8 Supplements Older Adults Should Ask Their Pharmacist About Before Buying Again Walk into almost any pharmacy, and you’ll find shelves filled with supplements promising better memory, stronger bones, healthier joints, and improved heart health. For older...
Reason · Oct 25 Vinay Prasad on Anthony Fauci, COVID-19 Restrictions, and RFK Jr. "Fauci was wrong about almost every single pandemic policy he advanced," the former FDA insider tells Reason.
Saving Advice · Oct 23 7 Signs Your Body May Not Be Handling Medication the Way It Used To That prescription you’ve taken safely for 15 years might not affect your body the same way it did when you first started taking it. Perhaps...
MarketBeat · Oct 23 3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach Lincoln National, AbbVie and Phillips 66 offer dividends that pay investors through midterm volatility, backed by rising rates, steady drug demand and oil risk.
Medical Daily · Oct 23 Ultomiris Wins Accelerated FDA Approval for IgA Nephropathy After Trial Showed 43% Greater Drop in Urine Protein FDA granted Ultomiris accelerated approval for IgA nephropathy based on lower urine protein. What it means and the infection risks to know.
Medical Daily · Oct 23 Listeria Outbreak with No Named Food Source Reaches 46 Illnesses as FDA Begins On-Site Inspection and Sampling A Listeria outbreak with no named food has reached 46 illnesses as the FDA begins inspections and sampling. See who is at risk and what to watch for.
Medical Daily · Oct 22 Americans Traveling to China for Cancer Drugs Not Yet Sold at Home Leave FDA Protections Behind More Americans are seeking cancer drugs and trials in China. Here is what changes outside FDA oversight and how to evaluate a foreign treatment.